WELLINGTON MANAGEMENT GROUP LLP

Position in NUVB — Nuvation Bio Inc.

CIK 902219 Boston, MA

Position in NUVB

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,883,496

-$5,180,394 QoQ

Shares Held

672,144

-25.3% QoQ

Ownership

0.193%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 0% Shared 71% None 29%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. NUVB ranks #96 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,883,496	672,144	-25.3%	Shares	Defined	2026-05-15
2025-12-31	$8,063,890	899,988	+3.6%	Shares	Defined	2026-02-17
2025-09-30	$3,213,559	868,530	+18.4%	Shares	Defined	2025-11-14
2025-06-30	$1,430,406	733,542	+5.9%	Shares	Defined	2025-08-14
2025-03-31	$1,219,104	692,673	+2.5%	Shares	Defined	2025-05-13
2024-12-31	$1,798,223	676,024	+8.3%	Shares	Defined	2025-02-12
2024-09-30	$1,428,897	623,973	+83.3%	Shares	Defined	2024-11-14
2024-06-30	$993,765	340,331	-57.9%	Shares	Defined	2024-08-14
2021-03-31	$8,446,995	808,325	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.